The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Long-term treatment of uterine fibroids with ulipristal acetate☆
Open accessAbstract
OBJECTIVE: To investigate the efficacy and safety of ulipristal acetate (UPA) for long-term treatment of symptomatic uterine fibroids. DESIGN: Repeated intermittent open-label UPA courses, each followed by randomized double-blind norethisterone acetate (NETA) or placebo. SETTING: European clinical gynecology centers. PATIENT(S): Two hundred and nine women with symptomatic fibroids including heavy menstrual bleeding. INTERVENTION(S): Patients received up to four 3-month courses of UPA 10 mg daily, immediately followed by 10-day double-blind treatment with NETA (10 mg daily) or placebo. MAIN OUTCOME MEASURE(S): Amenorrhea, fibroid volume, endometrial histology. RESULT(S): After the first UPA course, amenorrhea occurred in 79% of women, with median onset (from treatment start) of 4 days (interquartile range, 2-6 days). Median fibroid volume change was -45% (interquartile range, -66%; -25%). Amenorrhea rates were 89%, 88%, and 90% for the 131, 119, and 107 women who received treatment courses 2, 3, and 4, respectively. Median times to amenorrhea were 2, 3, and 3 days for treatment courses 2, 3, and 4, respectively. Median fibroid volume changes from baseline were -63%, -67%, and -72% after treatment courses 2, 3, and 4, respectively. All endometrial biopsies showed benign histology without hyperplasia; NETA did not affect fibroid volume or endometrial histology. CONCLUSION(S): Repeated 3-month UPA courses effectively control bleeding and shrink fibroids in patients with symptomatic fibroids. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (www.clinicaltrials.gov) registration numbers NCT01156857 (PEARL III) and NCT01252069 (PEARL III extension).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544
The short-form McGill pain questionnaire
Melzack, R. (1987) · Pain · doi:10.1016/0304-3959(87)91074-8 · Cited by 4,368
Assessment of menstrual blood loss using a pictorial chart
HIGHAM, J. M., O'BRIEN, P. M. S., & SHAW, R. W. (1990) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb16249.x · Cited by 1,116
Stewart, E. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03622-9 · Cited by 1,031
Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
Donnez, J., Tatarchuk, T. F., Bouchard, P., Puscasiu, L., Zakharenko, N. F., Ivanova, T., Ugocsai, G., Mara, M., Jilla, M. P., Bestel, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103182 · Cited by 680
Self-citationSpies, J. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01702-1 · Cited by 647
Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids
Donnez, J., Tomaszewski, J., Vázquez, F., Bouchard, P., Lemieszczuk, B., Baró, F., Nouri, K., Selvaggi, L., Sodowski, K., Bestel, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103180 · Cited by 607
Self-citationUterine Myomas: An Overview of Development, Clinical Features, and Management
Wallach, E. E., & Vlahos, N. F. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000136079.62513.39 · Cited by 540
What are the implications of myomas on fertility?
Donnez, J., & Jadoul, P. (2002) · Human Reproduction · doi:10.1093/humrep/17.6.1424 · Cited by 350
Self-citationCharacterization of Uterine Leiomyomas by Whole-Genome Sequencing
Mehine, M., Kaasinen, E., Mäkinen, N., Katainen, R., Kämpjärvi, K., Pitkänen, E., Heinonen, H.-R., Bützow, R., Kilpivaara, O., Kuosmanen, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302736 · Cited by 344
JANSSEN, C., SCHOLTEN, P., & HEINTZ, A. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00062-v · Cited by 292
The spectrum of endometrial pathology induced by progesterone receptor modulators
Mutter, G. L., Bergeron, C., Deligdisch, L., Ferenczy, A., Glant, M., Merino, M., Williams, A. R. W., & Blithe, D. L. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.19 · Cited by 236
Fiscella, K., Eisinger, S. H., Meldrum, S., Feng, C., Fisher, S. G., & Guzick, D. S. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000243776.23391.7b · Cited by 193
The role of progesterone signaling in the pathogenesis of uterine leiomyoma
Kim, J. J., & Sefton, E. C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.05.044 · Cited by 192
CDB-2914 for Uterine Leiomyomata Treatment
Levens, E. D., Potlog‐Nahari, C., Armstrong, A. Y., WESLEY, R. A., Premkumar, A., Blithe, D., Blocker, W., & Nieman, L. K. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181705d0e · Cited by 156
Williams, A. R. W., Bergeron, C., Barlow, D. H., & Ferenczy, A. S. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e318251035b · Cited by 155
Self-citationKouides, P. A., Byams, V. R., Philipp, C. S., Stein, S. F., Heit, J. A., Lukes, A. S., Skerrette, N. I., Dowling, N. F., Evatt, B. L., Miller, C. H., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07610.x · Cited by 145
Fibroids (uterine myomatosis, leiomyomas).
Lethaby, A. E., & Vollenhoven, B. (2005) · PubMed · Cited by 139
Zakherah, M. S., Sayed, G. H., El‐Nashar, S. A., & Shaaban, M. M. (2011) · Gynecologic and Obstetric Investigation · doi:10.1159/000320336 · Cited by 127
Intrauterine device use among women with uterine fibroids: a systematic review
Zapata, L. B., Whiteman, M. K., Tepper, N. K., Jamieson, D. J., Marchbanks, P. A., & Curtis, K. M. (2010) · Contraception · doi:10.1016/j.contraception.2010.02.011 · Cited by 126
Nieman, L. K., Blocker, W., Nansel, T. R., Mahoney, S. F., Reynolds, J. C., Blithe, D., WESLEY, R. A., & Armstrong, A. Y. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.09.059 · Cited by 123
Reid, P., & Virtanen‐Kari, S. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00642.x · Cited by 113
Donnez, J., Schrurs, B., Gillerot, S., Sandow, J., & Clerckx, F. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60723-9 · Cited by 106
Self-citationKadir, R. A., Lee, C. A., Sabin, C. A., Pollard, D., & Economides, D. L. (2002) · Haemophilia · doi:10.1046/j.1365-2516.2002.00678.x · Cited by 74
Ioffe, O. B., Zaino, R. J., & Mutter, G. L. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.204 · Cited by 69
Philipp, C. S., Faiz, A. S., Heit, J. A., Kouides, P. A., Lukes, A. S., Stein, S. F., Byams, V. R., Miller, C. H., & Kulkarni, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.10.897 · Cited by 69
Pharmacologic properties of CDB(VA)-2914
Gainer, E., & Ulmann, A. (2003) · Steroids · doi:10.1016/s0039-128x(03)00130-2 · Cited by 62
Horak, P., Mára, M., Dundr, P., Kubínová, K., Kuzel, D., Hudeček, R., & Chmel, R. (2012) · International Journal of Endocrinology · doi:10.1155/2012/436174 · Cited by 58
Fiscella, J., Bonfiglio, T. A., Winters, P., Eisinger, S. H., & Fiscella, K. A. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.11.003 · Cited by 58
Efficacy and safety of ormeloxifene in management of menorrhagia: A pilot study
Kriplani, A., Kulshrestha, V., & Agarwal, N. (2009) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2008.00987.x · Cited by 52
Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day
Pohl, O., Osterloh, I. H., & Gotteland, J. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12065 · Cited by 38
Self-citationPharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment
Melis, G. B., Piras, B., Marotto, M. F., Orrù, M., Maricosu, G., Pilloni, M., Guerriero, S., Angiolucci, M., Lello, S., & Paoletti, A. M. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.695775 · Cited by 35
Scialli, A. R., & Jestila, K. J. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57729-2 · Cited by 35
Uterine Fibroids and Evidence-Based Medicine — Not an Oxymoron
Stewart, E. A. (2012) · New England Journal of Medicine · doi:10.1056/nejme1114043 · Cited by 25
Cited by
Uterine fibroid management: From the present to the future
Donnez, J., & Dolmans, M.-M. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw023 · Cited by 780
Self-citationThe Management of Uterine Leiomyomas
Vilos, G. A., Allaire, C., Laberge, P.-Y., Leyland, N., Vilos, A. G., Murji, A., & Chen, I. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30338-8 · Cited by 642
Stewart, E. A., Laughlin-Tommaso, S. K., Catherino, W. H., Lalitkumar, S., Gupta, D., & Vollenhoven, B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.43 · Cited by 531
Stewart, E. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1411029 · Cited by 403
Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Patel, B., Elguero, S., Thakore, S., Dahoud, W., Bedaiwy, M., & Mesiano, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu056 · Cited by 353
Metadata
- Authors
- Donnez, J., Vázquez, F., Tomaszewski, J., Nouri, K., Bouchard, P., Fauser, B. C. J. M., Barlow, D. H., Palacios, S., Donnez, O., Bestel, E., Osterloh, I., & Loumaye, E.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 101
- Issue
- 6
- Pages
- 1565-1573.e18
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W1996100965
- Cited by
- 332
- References
- 34
- FWCI
- 49.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.